首页> 中文期刊> 《中国医学影像学杂志》 >多参数MRI的BI-RADS分类对乳腺病变的诊断效能

多参数MRI的BI-RADS分类对乳腺病变的诊断效能

             

摘要

目的:建立一种多参数乳腺MRI检查与诊断方式,与美国放射学院乳腺影像报告和数据系统(BI-RADS)分类对应,改进乳腺疾病的处理建议。资料与方法回顾分析278例乳腺疾病患者301个经病理证实的病灶,使用1 mm×1 mm×1 mm空间分辨率、120 s时间分辨率的动态增强扫描(DCE)序列和b=1000 s/mm2的扩散加权成像(DWI)序列进行扫描,将DCE显示早期病灶形态学恶性征象、时间-信号强度曲线(TIC)II型或III型、小于良恶性表观扩散系数(ADC)阈值的3个诊断因素各计1分,肿块和非肿块样强化病灶区别对待,积分≥2分诊断为BI-RADS 5类,积分=1分诊断为BI-RADS 4类,积分<1分诊断为BI-RADS 3类,其他特异性良性发现诊断为BI-RADS 2类,DCE和DWI无异常发现评价为BI-RADS 1类,并与病理学的良性(B)-高危(HR)-恶性(M)病灶分级进行对照,评价其对病灶处理的建议。结果以HR作为恶性时(M+HR),得到的ROC曲线下面积为0.860;以HR作为良性时(B+HR),得到的ROC曲线下面积为0.876,两者很接近。经过ROC曲线优化,在病理上将HR作为良性、在MRI上将BI-RADS 5类作为恶性,获得敏感度为85.3%,特异度为86.8%,准确度为85.1%,高于其他组合。如果将病理上HR病灶的处理原则定义为局部切除或短期随访,则BI-RADS 5类对M+HR病灶(可切除病灶)阳性预测值为93.2%;BI-RADS 4类病灶对M+HR病灶的阳性预测值为46.9%,必须活检以决定局部切除或短期随访;BI-RADS 3类及以下对B+HR病灶的阳性预测值(随访观察)为90.4%。结论本研究建立了一个简单的诊断模型,动态增强显示的形态学特征、动态时间-信号强度曲线和DWI-ADC值取相同的权重进行BI-RADS分类,可以很好地预测乳腺病灶良性、高危和恶性特征,对指导乳腺疾病的处理方式有实用价值。%PurposeTo investigate a multi-parametric protocol for breast MRI examination and lesions assessment correlated to the American College of Radiology (ACR) breast imaging reporting and data system (BI-RADS) categorization, and to improve the management of the breast lesions.Materials and Methods 301 pathologically confirmed lesions on 278 patients were retrospectively included. The scan protocol used a dynamic contrast enhancement sequence (DCE) of 1 mm×1 mm×1 mm spatial resolution, 120 temporal resolution and a diffusion weighted imaging (DWI) of b=1000 s/mm2. The malignant morphological features on the early-enhanced images, type II or III time intensity curve and the apparent diffusion coefficient (ADC) value less than benign/malignant threshold was equally weighted. Each was given 1 point when present malignant features and treated different on mass and non-mass-like enhancement lesions. When the sum of score was ≥2 points, the lesion was categorized as BI-RADS 5. When the sum of score was 1 point, the lesion was categorized as BI-RADS 4. When the sum of score was <1 point, the lesion was categorized as BI-RADS 3. The other specific benign findings were categorized as BI-RADS 2. No abnormality on DWI, DCE, T2WI and T1WI was categorized as BI-RADS 1. The final categories were correlated to the pathological grades as benign (B), high risk (HR) and malignant (M).Results When grouped HR as malignant (M+HR), the area under curve (AUC) of the ROC was 0.860. When grouped HR as benign (B+HR), the AUC of the ROC was 0.876, and the optimized sensitivity, specificity and accuracy was 85.3%, 86.8% and 85.1%, respectively, which were better than the other grouping. If the management of HR lesions could be lumptoectomy or short-term follow-up, the positive predictive value (PPV) of BI-RADS 5 for excisable lesions (M+HR) was 93.2%, the PPV of BI-RADS 4 for excisable lesions (M+HR) was 46.9% and the biopsy was essential. The PPV of BI-RADS 3 and below for follow-up lesions (B+HR) was 90.4%.Conclusion A simple diagnosis algorithm was established, which equally weighted the DCE morphological feature, DCE-TIC and DWI-ADC. The diagnosis protocol was well consistent with BI-RADS categorization and could predict the benign, high risk and malignant lesions in pathology as well as the proper management.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号